# Nuclide record idea-reg-ac225-accelerator-pharmacopoeia (idea). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/ideas/idea-reg-ac225-accelerator-pharmacopoeia/>
  a schema:CreativeWork ;
  nuclide:kind "idea" ;
  schema:identifier "idea-reg-ac225-accelerator-pharmacopoeia" ;
  schema:name "Regional cyclotron hubs for actinium-225 with an agreed actinium-227 impurity limit"@en ;
  schema:description "Actinium-225 can be made in particle accelerators, but the product contains a trace of a long-lived impurity that regulators have not agreed how to handle. Settle the limit and build the hubs."@en ;
  schema:url <https://nuclide.cc/ideas/idea-reg-ac225-accelerator-pharmacopoeia/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2018.0977> ;
  nuclide:related <https://nuclide.cc/isotopes/ac-225/> ;
  nuclide:technologies <https://nuclide.cc/technologies/targeted-alpha-therapy/> ;
  nuclide:terms <https://nuclide.cc/terms/alpha-vs-beta/>, <https://nuclide.cc/terms/dosimetry/> ;
  nuclide:bottlenecks <https://nuclide.cc/bottlenecks/b-manufacturing-cell-therapy/> .